Form 4 for FULC Fulcrum Therapeutics, Inc.
Accepted 2022-05-10 00:00:00 ET · period of report 2022-05-06 · accession 0000899243-22-017416 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-10 | 2022-05-06 | FULC | Tourangeau Greg | Ctrl | A - Grant | $0.00 | +3,250 | 16.2K | +25% | $0 |
| D | 2022-05-10 | 2022-05-06 | FULC | Tourangeau Greg | Ctrl | A - Grant | $0.00 | +6,500 | 6,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-06 | A | A | 3,250 | $0.00 | 16,202 | D | — | — | (F1) These shares represent restricted stock unit (RSU) awards granted on May 6, 2022, with each RSU representing a right to receive one share of common stock. The RSU is subject to time-based vesting with (i) 25% of the shares vesting on May 6, 2023, (ii) 25% of the shares vesting on May 6, 2024, and (iii) 50% of the shares vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2022-05-06 | A | A | 6,500 | $0.00 | 6,500 | D | $8.63 · — to 2032-05-05 | 6,500 Common Stock | (F2) This option was granted on May 6, 2022 and is subject to time-based vesting, with (i) 25% of the options vesting on May 6, 2023, (ii) 25% of the options vesting on May 6, 2024, and (iii) 50% of the options vesting on May 6, 2025, subject to the reporting person's continued service on each such vesting date. |